UPMC and University of Pittsburgh physician leaders recently shared new data on how certain UPMC patients with weak immune systems have responded to COVID-19 vaccination and offered clinical recommendations in light of these findings. They also provided an update on UPMC’s COVID-19 vaccination and monoclonal antibody treatments in the communities we serve.
An NCI-designated Comprehensive Cancer Center, affiliated with the University of Pittsburgh School of Medicine
Research
